Autosomal Recessive Demyelinating Charcot-Marie-Tooth Neuropathy Type 4K (CMT4K)

Autosomal recessive demyelinating Charcot-Marie-Tooth neuropathy type 4K (often shortened to CMT4K) is a very rare inherited disease that affects the peripheral nerves, which are the long nerves that carry signals between the brain, spinal cord, and the muscles and skin. In this condition the insulating layer (myelin) around the nerves is mainly damaged, so signals travel very slowly and become weak. Children usually start to show problems in the first decade of life, with weakness and thinning of the muscles of the feet and lower legs, and later the hands. Many patients also have reduced feeling in the hands and feet, absent tendon reflexes, and high-arched feet. Some people develop eye movement problems such as nystagmus and later cerebellar ataxia (unsteady movements). Blood tests often show raised lactate and a specific defect of mitochondrial respiratory chain complex IV. Biocodify+4NCBI+4MalaCards+4

Autosomal recessive demyelinating Charcot-Marie-Tooth neuropathy type 4K (CMT4K) is a very rare inherited nerve disease. It happens when a child receives two changed copies of the SURF1 gene, one from each parent. This gene problem damages the “myelin” coating around peripheral nerves, which slows down nerve signals. Children usually show symptoms in the first decade of life with weakness and thinning of muscles in the feet and hands, trouble walking, and reduced feeling in the limbs. Some people also develop eye movement problems (nystagmus), balance problems (ataxia), and lab findings like high blood lactate and mitochondrial complex IV deficiency. There is no cure yet, so treatment focuses on symptoms, function, and quality of life. NCBI+1

CMT4K follows an autosomal recessive inheritance pattern. This means a child is affected when they receive one faulty copy of the responsible gene from each parent. The main gene linked to this type is SURF1, which helps the cell build complex IV of the mitochondrial respiratory chain. When SURF1 does not work properly, nerve cells, especially Schwann cells that make myelin, cannot produce enough energy. Over time this energy failure leads to demyelination and secondary damage to the nerve fibers, giving the clinical picture of a severe, early-onset demyelinating neuropathy combined with signs of mitochondrial disease such as lactic acidosis. PMC+3MalaCards+3Orpha+3

Other names

CMT4K is known in the medical literature by several different names. These names all describe the same disease but focus on different aspects such as inheritance, type of nerve damage, or the responsible gene. Common alternative names include: “Charcot-Marie-Tooth disease type 4K,” “Charcot-Marie-Tooth disease, demyelinating, autosomal recessive, type 4K,” “autosomal recessive demyelinating Charcot-Marie-Tooth neuropathy type 4K,” and “SURF1-related Charcot-Marie-Tooth disease type 4” or “SURF1-related severe demyelinating Charcot-Marie-Tooth disease.” These terms all highlight that the condition is inherited in an autosomal recessive way, involves demyelination, and is linked to SURF1 gene variants. Orpha+3National Organization for Rare Disorders+3ZFIN+3

Types (clinical patterns)

Doctors do not have official “subtypes” of CMT4K in the same way as for some other diseases. However, based on reported patients and general knowledge about inherited demyelinating Charcot-Marie-Tooth disease, clinicians often think in terms of several clinical patterns. These patterns help describe severity and age of onset, but they are not strict categories and can overlap. neurology-asia.org+3MalaCards+3NCBI+3

1. Classic childhood-onset CMT4K – This is the most typical pattern. Children begin to show distal leg weakness, frequent tripping, and high-arched feet in early school years. Nerve conduction studies show very slow conduction, consistent with a demyelinating neuropathy. Symptoms rise slowly but steadily over time, and both arms and legs become involved. MalaCards+2NCBI+2

2. Early-infantile severe form – In some families, symptoms start in the first few years of life with marked hypotonia (floppiness), very delayed motor milestones, and early foot deformities. Because of the strong mitochondrial complex IV defect, these children may also have more systemic problems, including higher lactate levels and episodes of metabolic decompensation. PMC+3MalaCards+3Orpha+3

3. Childhood-onset with prominent cerebellar signs – A third pattern includes the usual neuropathy plus later development of nystagmus and cerebellar ataxia. In these patients, MRI may show cerebellar involvement, reflecting the broader effect of SURF1-related mitochondrial dysfunction beyond the peripheral nerves. PMC+3NCBI+3MalaCards+3

4. Mild juvenile or adolescent presentation – A few individuals may present later with milder distal weakness and sensory loss and remain able to walk for many years. Even in these milder cases, nerve conduction studies usually confirm a demyelinating neuropathy and genetic testing still reveals biallelic SURF1 variants. www.elsevier.com+3MalaCards+3Biocodify+3

Causes

The true primary cause of autosomal recessive demyelinating Charcot-Marie-Tooth neuropathy type 4K is being born with two disease-causing variants in the SURF1 gene, one from each parent. All other “causes” below are ways this genetic problem appears, or factors that change its expression or severity. MalaCards+2Orpha+2

1. Biallelic pathogenic SURF1 variants – CMT4K occurs when both copies of the SURF1 gene carry pathogenic variants (mutations). SURF1 helps assemble complex IV (cytochrome-c oxidase) in mitochondria, and loss of function leads to complex IV deficiency and neuropathy. Orpha+2Biocodify+2

2. Nonsense or frameshift variants in SURF1 – Truncating variants create a very short, non-functional SURF1 protein. This often causes a severe complex IV defect and an early-onset, aggressive neuropathy. Orpha+2Biocodify+2

3. Missense variants in SURF1 – Some patients have missense changes that swap one amino acid for another but still disrupt the protein’s function. Depending on the exact location and effect on the protein, disease severity can vary from moderate to severe. Orpha+2ResearchGate+2

4. Compound heterozygosity – Many affected people inherit two different faulty SURF1 variants, one from each parent. This “compound heterozygous” pattern is still autosomal recessive and has similar functional consequences for mitochondrial complex IV. Orpha+2balkanmedicaljournal.org+2

5. Consanguinity (parents related by blood) – When parents are related, they are more likely to carry the same rare pathogenic variant. This increases the chance that a child will inherit two faulty copies of SURF1 and develop CMT4K. balkanmedicaljournal.org+2neurology-asia.org+2

6. Mitochondrial complex IV assembly failure – SURF1 helps assemble complex IV in mitochondria. Without it, complex IV is unstable or missing, leading to reduced energy production, especially in high-demand tissues such as peripheral nerves and the cerebellum. Orpha+2Biocodify+2

7. Energy failure in Schwann cells – Schwann cells form and maintain myelin in peripheral nerves. When their mitochondria cannot produce enough energy, myelin breaks down, causing demyelination and slowed nerve conduction velocities. PFM Journal+2PMC+2

8. Secondary axonal degeneration – Long-standing demyelination stresses nerve fibers and can lead to axonal loss. Over time, this secondary axonal damage contributes to muscle atrophy and sensory loss in CMT4K. ScienceDirect+2neurology-asia.org+2

9. Increased oxidative stress – Mitochondrial respiratory chain defects often increase reactive oxygen species. Excess oxidative stress can further damage nerve cells and Schwann cells, worsening neuropathy. ScienceDirect+2PMC+2

10. High energy demands of long peripheral nerves – The longest nerves to the feet and hands have high energy needs. In CMT4K, limited mitochondrial capacity makes these nerves especially vulnerable, which explains the “length-dependent” pattern where feet are affected first. PFM Journal+2ScienceDirect+2

11. Modifier genes in other neuropathy-related pathways – Variants in other genes that influence myelin, axons, or mitochondria may modify the severity or age at onset of CMT4K, even though SURF1 remains the main causal gene. PFM Journal+2ScienceDirect+2

12. Founder variants in specific populations – In some countries or ethnic groups, one specific SURF1 variant may be relatively common because of a founder effect, leading to clusters of cases. MalaCards+2ResearchGate+2

13. Perinatal or early-childhood metabolic stress – Severe infections, fever, or poor nutrition in infants with SURF1 variants may expose their limited mitochondrial reserve earlier, making the neuropathy appear sooner or more dramatically. PMC+2AAFP+2

14. Coexisting nutritional deficiencies – Lack of vitamins such as B12 does not cause CMT4K but may further harm peripheral nerves in a child who already has SURF1-related demyelinating neuropathy, leading to a more severe clinical picture. AAFP+2Springer+2

15. Exposure to mitochondrial toxins – Certain medications or toxins that stress mitochondria (for example, some antibiotics or chemotherapies) can worsen symptoms in a patient with underlying SURF1-related mitochondrial dysfunction. AAFP+2ScienceDirect+2

16. Poorly controlled systemic illnesses – Conditions such as diabetes or thyroid disease are not primary causes of CMT4K, but if they occur in an affected person, they can add further peripheral nerve damage and increase disability. AAFP+2Springer+2

17. Repeated mechanical stress on weak limbs – Chronic strain on already weak muscles and joints can accelerate contractures and deformities and indirectly contribute to worsening disability in CMT4K. neurology-asia.org+2www.elsevier.com+2

18. Delayed recognition and lack of early supportive care – When diagnosis is delayed, children may not receive braces, physiotherapy, or fall-prevention strategies, which can lead to faster secondary complications, though the genetic defect itself is unchanged. Taylor & Francis Online+2www.elsevier.com+2

19. New (de novo) SURF1 variants – Very rarely, a pathogenic SURF1 variant may arise for the first time in a family. If the other parent is a carrier, the child can still have biallelic disease. This is uncommon but represents another genetic pathway to CMT4K. balkanmedicaljournal.org+2ResearchGate+2

20. Autosomal recessive inheritance across generations – In many families, carriers are healthy and the disease appears only when two carriers have a child. This recessive inheritance pattern is the fundamental genetic “cause” that explains why CMT4K often affects siblings but not parents. neurology-asia.org+3MalaCards+3NCBI+3

Symptoms

The symptoms of CMT4K mainly reflect slowly progressive damage to motor and sensory fibers in the longest peripheral nerves, with additional cerebellar and mitochondrial features in some patients. PMC+4MalaCards+4NCBI+4

1. Distal leg weakness – One of the earliest signs is weakness in the muscles that lift the foot and toes. Children may have trouble running, hopping, or keeping up with peers during sports. This reflects length-dependent motor neuropathy. MalaCards+2PFM Journal+2

2. Foot drop and frequent tripping – Because ankle dorsiflexors are weak, the toes drag during walking, causing repeated tripping or a “slapping” gait. Many children learn to lift their knees higher to avoid falling, producing a steppage gait. PFM Journal+2ScienceDirect+2

3. High-arched feet (pes cavus) – Over time, muscle imbalance in the feet leads to high arches, clawing of the toes, and sometimes hammer toes. These deformities are very common in inherited demyelinating CMT and often seen in CMT4K. www.elsevier.com+3MalaCards+3PFM Journal+3

4. Calf and distal leg muscle wasting – As motor axons degenerate, the muscles of the lower legs become thin, giving a “stork-leg” appearance. This wasting is usually symmetric and slowly progressive. PFM Journal+2ScienceDirect+2

5. Weakness in the hands – Later in the disease, small muscles of the hands can become weak. Children or adults may struggle with buttons, zippers, handwriting, or opening jars, reflecting spread of the neuropathy to upper-limb nerves. PFM Journal+2ScienceDirect+2

6. Distal sensory loss – Many patients notice numbness, reduced ability to feel vibration, or a “cotton” feeling under the feet. This starts in the toes and moves upward, and later can affect the fingertips, as sensory fibers are damaged. MalaCards+2PFM Journal+2

7. Tingling or burning sensations – Abnormal signals in damaged sensory nerves can cause tingling, pins-and-needles, or burning pain in the feet and hands. Not all patients have pain, but it can be troublesome in some. AAFP+2Springer+2

8. Absent or reduced tendon reflexes – Doctors often find that ankle and sometimes knee reflexes are very weak or absent. This is a classic sign of peripheral neuropathy and fits with the demyelinating nature of CMT4K. MalaCards+2PFM Journal+2

9. Balance problems and unsteady walking – Loss of position sense in the feet and weakness of distal muscles make it hard to keep balance, especially in the dark or on uneven ground. Patients may sway or fall easily. PFM Journal+2ScienceDirect+2

10. Nystagmus (jerky eye movements) – Some people with CMT4K develop involuntary, rhythmic eye movements. This suggests involvement of brainstem or cerebellar pathways and is consistent with SURF1-related mitochondrial dysfunction. PMC+3NCBI+3MalaCards+3

11. Cerebellar ataxia – A subset of patients develop broad-based gait, clumsiness, and difficulty with precise limb movements because the cerebellum is affected. This can appear later in the disease course. PMC+3NCBI+3MalaCards+3

12. Fatigue and exercise intolerance – Mitochondrial dysfunction and neuropathy together can cause tiredness with relatively small amounts of activity. Patients may need frequent rest and have difficulty with sustained walking or standing. Biocodify+2PMC+2

13. Skeletal deformities and contractures – Long-term imbalance between weak and relatively stronger muscles may result in fixed deformities, including Achilles tendon tightening, ankle equinus, or mild scoliosis. PFM Journal+2www.elsevier.com+2

14. Fine motor coordination problems – Even when strength is only mildly reduced, impaired sensory feedback and mild cerebellar involvement can make tasks like writing or typing slower and less precise. PFM Journal+2ScienceDirect+2

15. Psychosocial impact – Chronic disability, visible foot deformities, and fatigue may affect self-esteem, schooling, and social life, especially in adolescents. Support, counseling, and adaptations are often needed although the primary cause remains neurological. PMC+2Taylor & Francis Online+2

Diagnostic tests

Diagnosing autosomal recessive demyelinating Charcot-Marie-Tooth neuropathy type 4K relies on combining clinical examination, electrodiagnostic studies, laboratory and genetic tests, and imaging. The goal is to confirm a demyelinating inherited neuropathy and identify biallelic SURF1 variants with associated mitochondrial complex IV deficiency. Springer+4MalaCards+4NCBI+4

Physical examination tests

1. General neurological examination – The doctor looks for muscle weakness, muscle bulk, tone, reflexes, and sensory changes. In CMT4K they typically find distal weakness, muscle wasting, reduced reflexes, and length-dependent sensory loss, which together suggest a peripheral neuropathy. PFM Journal+2ScienceDirect+2

2. Gait and posture assessment – The clinician watches the patient walk, run, and stand. A steppage gait, frequent tripping, and difficulty walking on heels are common in demyelinating CMT. Observation may also show imbalance or ataxia in those with cerebellar involvement. PFM Journal+2neurology-asia.org+2

3. Foot and spine inspection – The doctor checks for pes cavus, claw toes, calluses, ankle contractures, and scoliosis. These structural changes support a long-standing neuropathy and help distinguish inherited neuropathies from acute acquired causes. PFM Journal+2www.elsevier.com+2

4. Cranial nerve and eye movement examination – Eye movements are evaluated for nystagmus, and tests of coordination such as finger-to-nose help identify cerebellar signs, which are reported in some patients with CMT4K. PMC+3NCBI+3MalaCards+3

Manual bedside tests

5. Manual muscle testing (MRC scale) – The examiner grades strength (from 0 to 5) in key muscle groups. In CMT4K, distal muscles of the feet and hands are usually weaker than proximal muscles, and scores may decline slowly over time, helping to monitor disease progression. PFM Journal+2ScienceDirect+2

6. Sensory testing for light touch, pin, and vibration – Using cotton, a pin, and a tuning fork, the doctor tests different types of sensation. Reduced vibration and pinprick in a “stocking-and-glove” pattern are typical for length-dependent peripheral neuropathy. AAFP+2Springer+2

7. Romberg test and balance checks – The patient stands with feet together and then with eyes closed. Increased swaying or falling suggests loss of proprioception from large sensory fibers, which fits with demyelinating CMT. AAFP+2Springer+2

8. Functional hand tests (grip and fine motor tasks) – Simple tasks such as gripping a dynamometer, writing, buttoning, or picking up small objects reveal subtle hand weakness and coordination problems that may not be obvious on routine strength testing. PFM Journal+2ScienceDirect+2

Laboratory and pathological tests

9. Serum lactate and pyruvate – Many patients with CMT4K have raised blood lactate because of mitochondrial complex IV deficiency. Measuring lactate and pyruvate helps support the idea of a mitochondrial disorder alongside the neuropathy. MalaCards+2Biocodify+2

10. Basic blood tests to rule out acquired neuropathies – Tests such as full blood count, glucose, vitamin B12, folate, thyroid function, and kidney and liver function help exclude common acquired causes of neuropathy. This makes it more likely that the neuropathy is inherited. AAFP+2Springer+2

11. Creatine kinase (CK) – CK is a muscle enzyme that may be mildly raised due to chronic denervation and muscle wasting. While CK is not specific for CMT4K, it provides extra information about muscle damage and helps in the overall assessment. AAFP+2Springer+2

12. Arterial or venous blood gas analysis – This test can show metabolic acidosis and raised lactate, which are classical features of respiratory chain complex IV defects in some SURF1-related conditions and may also be present in CMT4K. Orpha+2Biocodify+2

13. Muscle biopsy with respiratory chain enzyme analysis – A small piece of muscle is examined under the microscope and tested for mitochondrial respiratory chain activity. In CMT4K, there is often isolated complex IV deficiency, which strongly supports SURF1-related disease. PMC+3MalaCards+3Orpha+3

14. Peripheral nerve biopsy – In selected cases, a sural nerve biopsy may show severe demyelination with onion bulb formations and signs of mitochondrial involvement. Because nerve biopsy is invasive, it is now used less often, especially when genetic testing is available. Springer+2UW Departments+2

Electrodiagnostic tests

15. Nerve conduction studies (NCS) – Electrodes are placed on the skin and nerves are stimulated with small electrical pulses. In CMT4K, conduction velocities are markedly slowed, confirming a demyelinating neuropathy and distinguishing it from primarily axonal forms. Springer+2NCBI+2

16. Electromyography (EMG) – A fine needle electrode is inserted into muscles to record electrical activity. EMG in CMT4K often shows chronic denervation and reinnervation changes, reflecting long-standing neuropathy. EMG helps exclude other neuromuscular disorders such as primary myopathies. NCBI+2UW Departments+2

17. Late responses (F-waves and H-reflexes) – These specialized nerve conduction measurements test the integrity of longer nerve segments and spinal reflex pathways. In demyelinating CMT, F-wave latencies are often prolonged or absent, and H-reflexes may be missing, supporting diffuse demyelination. UW Departments+2NCBI+2

Imaging tests

18. Brain MRI with attention to cerebellum and brainstem – MRI can show structural changes such as cerebellar atrophy in patients who develop ataxia or nystagmus. These findings support a broader SURF1-related mitochondrial disorder rather than a purely peripheral neuropathy. SciELO+3NCBI+3MalaCards+3

19. Spinal and nerve-root MRI / MR neurography – MRI of the spine and nerve roots is usually normal in CMT4K but can rule out compressive causes of neuropathy. MR neurography sequences can visualize peripheral nerves and sometimes show diffuse nerve enlargement in inherited neuropathies. IJMSR+2SciELO+2

20. Peripheral nerve ultrasound or calf muscle MRI – Ultrasound can assess nerve size and structure in the limbs, while MRI of the calves can show patterns of muscle atrophy and fatty replacement typical for inherited neuropathies. These imaging tools are increasingly used as non-invasive biomarkers in CMT. IJMSR+2ResearchGate+2

Non-Pharmacological Treatments

1. Physiotherapy and stretching programs
   Regular physiotherapy is one of the most important treatments for CMT4K. A gentle, long-term program of stretching helps keep joints flexible and reduces the risk of contractures (permanent stiffness). Simple daily stretches for ankles, knees, hips, hands, and fingers can slow deformity and make walking safer. A physiotherapist designs exercises based on strength, balance, and fatigue level so the child does not over-tire or injure muscles. Lippincott Journals+3PMC+3Muscular Dystrophy Association+3

2. Strength and resistance training
   Mild resistance exercises, such as elastic bands or light weights, can help preserve muscle strength around weak ankles, knees, and hands. The goal is not bodybuilding but maintaining the ability to stand, walk, and use the hands. Research in CMT shows that supervised strength training can improve or maintain function without making the disease progress faster, when done carefully and gradually. PubMed+2Wiley Online Library+2

3. Aerobic exercise
   Low-impact aerobic activities such as swimming, cycling, or walking in safe environments can improve heart fitness, stamina, and mood. For CMT4K, sessions need to be short at first and spaced with rest periods. Aerobic exercise may help reduce fatigue and support overall health, but it must be paced so that weakness does not get worse during or after the activity. PubMed+2ResearchGate+2

4. Balance and gait (walking) training
   Balance training uses simple tasks like standing on different surfaces, stepping over objects, and using parallel bars or harness systems. Gait training teaches safer walking patterns, often with video or mirror feedback. For people with foot drop and ankle weakness, these exercises reduce falls and improve confidence in daily walking. MDPI+2Charcot-Marie-Tooth Disease+2

5. Ankle-foot orthoses (AFOs) and other orthotic devices
   AFOs are light braces worn in shoes that hold the ankle at a safer angle and lift the toes to prevent tripping. Custom insoles and shoe inserts improve foot alignment and distribute pressure more evenly. In CMT, orthoses can delay foot deformity, improve walking speed, and reduce pain. Muscular Dystrophy Association+2Pod NMD+2

6. Special footwear and foot care
   Supportive shoes with firm heels, wide toe boxes, and non-slip soles help balance and comfort. Regular foot checks, nail care, and treatment of calluses are essential because numb feet can miss minor injuries that later become ulcers. A podiatrist can help with shoe choice and skin care plans. nhs.uk+1

7. Occupational therapy for hands and daily activities
   Occupational therapists teach easier ways to dress, wash, cook, write, and use devices when hand muscles become weak. They may suggest wrist splints, built-up pens, easy-grip tools, and computer adaptations. This support allows children and adults with CMT4K to stay independent at school, home, and work. Charcot-Marie-Tooth Association+1

8. Assistive mobility devices (canes, walkers, wheelchairs)
   Using a cane, crutches, or a walker is not a failure; it is a tool to prevent falls and keep energy for school, work, and social life. Some people with advanced CMT4K use a wheelchair for long distances but still walk short distances at home. Choosing the right device depends on strength, balance, and environment. Muscular Dystrophy Association+1

9. Home safety and fall-prevention changes
   Simple changes like removing loose rugs, adding grab bars in the bathroom, improving lighting, and using non-slip mats can greatly reduce injuries. Stairs may need handrails on both sides. An occupational therapist can visit the home, look at every room, and suggest practical changes tailored to the person’s abilities. Muscular Dystrophy Association+1

10. School and workplace accommodations
    Children may need extra time to move between classes, access to elevators, modified physical education, or note-taking support. Adults might need ergonomic chairs, footrests, or flexible hours. Legal frameworks in many countries protect the right to reasonable accommodations so that people with CMT can fully participate in education and work.

11. Pain self-management and psychological therapies
    Chronic neuropathic pain and fatigue can affect mood and sleep. Cognitive behavioral therapy (CBT), relaxation breathing, mindfulness, and pacing strategies can reduce the distress linked to pain even when the pain signals are still present. These methods are often used together with medical treatments, not instead of them. Charcot-Marie-Tooth Association+1

12. Energy conservation and fatigue management
    People with CMT4K often feel tired easily because weak muscles work harder. Planning the day, taking short rests before getting exhausted, using wheeled bags, and sitting for tasks like food preparation can protect energy. Therapists teach “work simplification” to use the strongest muscles and avoid repeated strain on weak ones. OAM Journal of Medical Sciences+1

13. Respiratory and speech therapy when needed
    In some severe neuromuscular disorders, breathing muscles or swallowing muscles can become weak. If this happens in CMT4K, respiratory therapists can teach coughing techniques and sometimes recommend devices to support breathing at night. Speech-language therapists help with safe swallowing and clear speech if needed.

14. Nutritional counseling and weight management
    Extra body weight makes walking harder for weak muscles and increases fall risk. A dietitian can help create a healthy plan that gives enough calories and protein for growing children but avoids excessive weight gain. Good nutrition also supports bone strength and immune health. nhs.uk+1

15. Psychological support and peer groups
    Living with a rare, progressive condition can cause sadness, anxiety, or feeling different from others. Talking with a counselor, psychologist, or social worker who understands chronic illness can help. Support groups—online or in person—allow families to share ideas and feel less alone. Charcot-Marie-Tooth Association+1

16. Genetic counseling for families
    Because CMT4K is autosomal recessive, parents are usually healthy carriers. A genetic counselor can explain recurrence risks for future pregnancies, talk about carrier testing for siblings, and discuss options such as prenatal diagnosis in some settings. This helps families make informed choices. NCBI+1

17. Regular neuromuscular clinic follow-up
    Ongoing reviews with a neurologist and multidisciplinary team allow early detection of new problems like scoliosis, foot deformities, or breathing issues. Timely adjustment of braces, therapies, or medications can make a big difference in long-term function and comfort. Muscular Dystrophy Association+1

18. Rehabilitation technology (treadmill, robotics, virtual reality)
    Some centers use treadmill training with body-weight support, robotic gait devices, or virtual reality balance games. These tools can make therapy more intensive and more motivating, but they must be used under professional supervision to avoid over-fatigue. Evidence in CMT is still limited but promising in improving walking and balance. MDPI+1

19. Hydrotherapy and swimming
    Warm-water therapy pools allow movement with less weight on joints. Swimming and water exercises help maintain strength and flexibility in a low-impact way and may reduce pain for some people. Careful supervision is needed because of possible balance problems around the pool. Muscular Dystrophy Association+1

20. Orthopedic and rehabilitation review before and after surgery
    Even when surgery is planned, non-drug care remains vital. Pre-surgery therapy prepares muscles and teaches use of walking aids. After surgery, rehabilitation helps the person learn new patterns of standing and walking and protect the surgical correction. PMC+2Charcot-Marie-Tooth Association+2

---

Drug Treatments (Medicines – Symptom-Based, Not Curative)

Important: There is no medicine that cures the SURF1 gene problem in CMT4K yet. Most drugs are used to treat neuropathic pain, muscle symptoms, mood, or sleep. Doses and schedules must always be set by a doctor, especially in children and teens. Some uses are “off-label” but based on general neuropathic pain evidence. FDA Access Data+6Charcot-Marie-Tooth Association+6Springer+6

1. Gabapentin
   Gabapentin is an anticonvulsant used widely for neuropathic pain. FDA labels describe its use for nerve pain after shingles at total daily doses titrated up over several days. It works mainly by binding to calcium channel subunits in the spinal cord and reducing the release of pain-signaling chemicals. Common side effects include sleepiness, dizziness, and swelling of legs. Doctors start low and increase slowly to balance pain relief and side effects. FDA Access Data+3FDA Access Data+3FDA Access Data+3

2. Pregabalin
   Pregabalin, related to gabapentin, is approved for several neuropathic pain conditions. It binds strongly to the α2-δ subunit of voltage-gated calcium channels and reduces the release of excitatory neurotransmitters. FDA labeling for neuropathic pain uses divided doses, slowly increased to a maximum daily dose depending on the indication and kidney function. Side effects often include dizziness, drowsiness, and swelling. FDA Access Data+3FDA Access Data+3FDA Access Data+3

3. Duloxetine
   Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) approved for diabetic peripheral neuropathic pain, fibromyalgia, depression, and anxiety. For nerve pain, the FDA label describes a usual adult dose of 60 mg once daily. It raises serotonin and norepinephrine levels in pain pathways, which can dampen pain signals. Side effects can include nausea, sleepiness, dry mouth, and increased sweating. FDA Access Data+3FDA Access Data+3FDA Access Data+3

4. Amitriptyline
   Amitriptyline is a tricyclic antidepressant often used at low doses at night for neuropathic pain and sleep problems. It blocks reuptake of serotonin and norepinephrine and also acts on sodium channels and other receptors, which can reduce pain. Side effects may include dry mouth, constipation, weight gain, and drowsiness. Dosing usually starts very low and increases slowly, especially in young people. Springer+1

5. Nortriptyline
   Nortriptyline is another tricyclic, sometimes better tolerated than amitriptyline because it is less sedating at similar doses. It is used off-label for neuropathic pain, with bedtime dosing to improve sleep and pain at the same time. Side effects are similar to amitriptyline and include dry mouth and dizziness, so heart history must be checked. Springer+1

6. Venlafaxine
   Venlafaxine is an SNRI that can help some people with neuropathic pain and depression. It works by increasing serotonin and norepinephrine in the brain and spinal cord. It is usually started at low doses with food and increased slowly. Side effects can include nausea, headache, and blood pressure changes, so monitoring is important. Charcot-Marie-Tooth Association+1

7. Carbamazepine
   Carbamazepine is an anticonvulsant often used for nerve pain such as trigeminal neuralgia. It stabilizes overactive sodium channels in nerve cells, which can reduce shooting or burning pain. It has many possible side effects, including dizziness and blood count changes, and can interact with other drugs, so blood tests and close medical supervision are needed. Best Practice Advocacy Centre

8. Lamotrigine
   Lamotrigine is another anticonvulsant sometimes tried for neuropathic pain when first-line drugs fail. It modulates sodium channels and glutamate release. Doses must be increased very slowly to reduce the risk of skin rash, including rare serious rashes. It may be used by specialists for difficult chronic pain situations. Best Practice Advocacy Centre

9. Lidocaine 5% topical patch
   Lidocaine patches are placed on painful skin areas, such as over the most sensitive part of a limb. Lidocaine blocks sodium channels in peripheral nerves, which reduces local pain without strong whole-body side effects. Patches are usually worn for a limited number of hours per day to avoid toxicity. Skin irritation is the most common problem. Springer+1

10. High-concentration capsaicin patch
    Capsaicin 8% patch is applied in a clinic to a painful area for a short time. It temporarily over-activates and then desensitizes pain fibers in the skin, which can reduce pain for several weeks or months. The procedure may cause burning sensations during and shortly after application, so it is usually done under medical supervision. Springer

11. Tramadol (short-term use only, with caution)
    Tramadol is a weak opioid that also affects serotonin and norepinephrine reuptake. It may be used for short-term severe pain when other options fail. Because it can cause dependence, drowsiness, and seizures in some people, guidelines often recommend it as a second-line or last-line choice, especially in young patients. Practical Neurology+1

12. Non-steroidal anti-inflammatory drugs (NSAIDs)
    Drugs such as ibuprofen or naproxen can help with musculoskeletal pain from joint strain and minor injuries but are less effective for pure neuropathic pain. They work by blocking cyclo-oxygenase enzymes that produce inflammatory prostaglandins. Long-term use can irritate the stomach and affect kidneys, so they must be used carefully and often at the lowest effective dose. Best Practice Advocacy Centre

13. Baclofen
    Baclofen is a muscle relaxant that acts on GABA-B receptors in the spinal cord and is sometimes used when muscle stiffness or spasms are a major problem. It can reduce tightness but may also cause weakness and sleepiness if the dose is too high. Dosing must be increased slowly and never stopped suddenly. Best Practice Advocacy Centre

14. Tizanidine
    Tizanidine is another antispasticity drug that works by stimulating alpha-2 adrenergic receptors, which reduces excitatory input to motor neurons. It may be used for muscle tone problems that interfere with walking or comfort. Common side effects include drowsiness and low blood pressure, so medical monitoring is needed. Best Practice Advocacy Centre

15. Clonazepam (short-term, specialist use)
    Clonazepam is a benzodiazepine that can help with severe anxiety, myoclonus, or sleep disturbance linked to pain. It enhances GABA signaling and calms overactive nerve circuits. Because of risks of dependence, daytime sleepiness, and falls, its use is usually limited and closely supervised. PMC+1

16. Melatonin or other simple sleep aids
    In some people, pain and tingling are worse at night and disturb sleep. Melatonin is a hormone supplement that can help regulate sleep-wake cycles. It does not treat neuropathy itself but may improve rest, which can indirectly improve coping with symptoms. Timing and dose should be discussed with a doctor, especially in children and teens. Frontiers

17. Selective serotonin reuptake inhibitors (SSRIs) for mood
    Drugs like sertraline or fluoxetine are mainly for depression and anxiety, not for pain directly. However, improving mood can reduce suffering and make physiotherapy and self-care easier. Doctors consider interactions with other medicines and adjust doses carefully. PMC

18. Vitamin B12 replacement when deficient
    If blood tests show vitamin B12 deficiency, injections or high-dose tablets can treat it and may improve nerve symptoms linked to the deficiency. B12 supports myelin formation and nerve repair, so correcting low levels is important in any neuropathy, even if it does not cure CMT4K. nhs.uk+3Cleveland Clinic+3PubMed+3

19. Pain-modulating topical creams (low-dose)
    Some people benefit from simple topical creams with combinations of local anesthetics or other agents to reduce burning or tingling sensations. These creams act locally on small nerve endings in the skin. Their effect is often mild but side effects are limited mostly to local irritation.

20. Medicines for associated conditions (mood, sleep, digestion)
    In CMT4K, doctors may also treat associated problems such as depression, anxiety, constipation, or stomach upset related to drugs or reduced activity. Treating these issues does not alter the neuropathy itself but strongly improves quality of life and makes the overall treatment plan more successful.

---

Dietary Molecular Supplements

Important: Supplements can interact with medicines or be unsafe at high doses. Always ask a doctor before starting any supplement, especially for a rare mitochondrial-related disease like CMT4K.

1. Alpha-lipoic acid (ALA)
   Alpha-lipoic acid is an antioxidant that helps mitochondria handle oxidative stress. Studies in diabetic neuropathy used doses around 600 mg per day and showed modest improvement in neuropathic symptoms, though newer reviews suggest benefits may be small. It may work by improving blood flow to nerves and reducing free-radical damage. In CMT4K, its use is extrapolated from other neuropathies and should be specialist-guided. MDPI+5PMC+5Diabetes Journals+5

2. Acetyl-L-carnitine (ALC)
   ALC helps transport fatty acids into mitochondria for energy and may support nerve repair. Trials in painful peripheral neuropathy show moderate pain reduction and improved nerve conduction with daily dosing under medical supervision. It may reduce pain by supporting mitochondrial function and promoting nerve fiber regeneration. In CMT4K, which involves mitochondrial complex IV problems, ALC is sometimes considered experimentally. Nature+3PMC+3PLOS+3

3. Coenzyme Q10 (CoQ10)
   CoQ10 is a key carrier in the mitochondrial electron transport chain and a strong antioxidant. In mitochondrial diseases, CoQ10 supplementation is often used as supportive therapy, with weight-based doses such as 5–15 mg/kg/day described in expert summaries. Evidence shows benefit in some mitochondrial deficiencies, though results are mixed. In CMT4K, with mitochondrial complex IV deficiency, CoQ10 may be considered as part of a specialist “mitochondrial cocktail.” ClinicalTrials+5PubMed+5ScienceDirect+5

4. B-complex vitamins (B1, B6, B12)
   Thiamine (B1), pyridoxine (B6), and cobalamin (B12) are essential for nerve metabolism and myelin formation. B12 deficiency is a well-known cause of neuropathy and must be corrected if present. Balanced B-complex supplementation at recommended doses may support general nerve health, but very high doses of B6 over long periods can themselves cause neuropathy, so dose limits are important. The Times of India+6Cleveland Clinic+6PubMed+6

5. Omega-3 fatty acids
   Omega-3 fatty acids from fish oil or algae support cell membrane health and have anti-inflammatory effects. They may help with general cardiovascular and brain health and could indirectly support nerve function, though evidence for specific benefit in CMT is limited. Typical doses are those used for heart health and must be balanced with bleeding risk if the person uses blood-thinning medicines. Frontiers

6. Vitamin D
   Vitamin D is important for bone strength, muscle function, and immune regulation. Many people with chronic illness or limited outdoor activity have low vitamin D levels. Correcting deficiency with appropriate daily or weekly doses can reduce fracture risk and may help muscle performance, which is important when nerves are weak. nhs.uk

7. Magnesium
   Magnesium plays a role in nerve and muscle function. Mild supplementation may help with muscle cramps in some people. However, high doses can cause diarrhea and, in kidney disease, dangerous magnesium levels. Therefore, magnesium should only be used in doses recommended by a healthcare professional. nhs.uk

8. Curcumin (turmeric extract)
   Curcumin has anti-inflammatory and antioxidant properties in experimental studies. It may be considered as part of a general anti-inflammatory lifestyle pattern, but data specifically in CMT or inherited neuropathy are very limited. It should not replace approved treatments and may interact with blood-thinning drugs. Frontiers

9. N-acetylcysteine (NAC)
   NAC supports glutathione production, an important antioxidant system, and has been explored in some nerve and mitochondrial conditions. It may help reduce oxidative stress, but clinical evidence in hereditary neuropathy is still weak. Dose and duration should be decided with a specialist because of possible interactions and side effects such as nausea. Frontiers+1

10. Probiotics and gut-support supplements
    Good gut health may support immune balance and drug absorption. Probiotics provide beneficial bacteria, and prebiotic fibers feed them. While they do not directly treat CMT4K, a healthy gut may help people better tolerate long-term medicines and maintain overall health. Choice of product and dose should consider age and any immune problems. Frontiers

---

Immunity-Boosting, Regenerative, and Stem-Cell-Related Drug

Very important: There are no approved stem-cell or gene-replacement drugs specifically for CMT4K at this time. The treatments below are either general supportive mitochondrial therapies or research-level approaches that should only be used in clinical trials or under specialist care. SAGE Journals+4CMT Research Foundation+4Institut Myologie+4

1. High-dose Coenzyme Q10 as mitochondrial support
   In mitochondrial disorders, high-dose CoQ10 (sometimes 5–15 mg/kg/day or higher under supervision) is used to support electron transport and reduce oxidative stress. It may improve fatigue and exercise tolerance in some patients. For CMT4K, which shows complex IV deficiency, this is considered a supportive, not curative, measure and should be guided by a mitochondrial specialist.

2. Gene therapy research (SURF1 gene replacement)
   Laboratory and early animal studies explore viral vectors that carry a healthy copy of genes into affected cells. For SURF1-related conditions, gene therapy aims to restore complex IV activity and improve mitochondrial function. This work is still in research phases; dosing, long-term safety, and real benefits are not yet established, so it is only available in clinical trials.

3. Mesenchymal stem-cell–based therapies (experimental)
   Mesenchymal stem cells from bone marrow or fat tissue are being studied for various neuropathies because they secrete growth factors and may modulate inflammation. Trials are small and early; there is no strong evidence to recommend routine use in CMT4K. Unregulated “stem cell clinics” are risky and should be avoided.

4. Neurotrophic factor–targeted therapies
   Some experimental approaches aim to increase neurotrophic factors (such as nerve growth factor or neurotrophin-3) to support axon survival and myelin repair. Various molecules and gene-based treatments are being studied in other types of CMT and inherited neuropathies. At present, they are not approved standard care but may appear in clinical trial lists from CMT research groups. ScienceDirect+1

5. Antioxidant “cocktails” used in mitochondrial medicine
   Specialists sometimes use combinations of CoQ10, riboflavin, thiamine, L-carnitine, and alpha-lipoic acid as a “mitochondrial cocktail” to support energy production and reduce oxidative damage. Evidence varies between components and diseases, and dosing is highly individualized. These treatments should be managed by clinicians experienced in mitochondrial disorders. PubMed+2ScienceDirect+2

6. Immune-modulating treatments in atypical cases
   If a person with known CMT4K also shows signs of superimposed inflammatory neuropathy (for example, sudden worsening with high inflammatory markers), immune therapies like intravenous immunoglobulin (IVIG) or corticosteroids may be considered. These do not treat the genetic CMT but may help the additional inflammatory process. Such decisions are complex and made only by neuromuscular specialists. ScienceDirect+1

---

Surgeries (Procedures and Why They Are Done)

1. Foot deformity correction (cavovarus reconstruction)
   Many people with CMT develop high arched feet, clawed toes, and heel varus that make walking painful and unstable. Surgery can include tendon transfers, plantar fascia release, and bone cuts (osteotomies) to realign the foot and balance muscles. The aim is to create a flatter, plantigrade foot that fits in a shoe, reduces pain, and lowers fall risk. EKB Journals+5PMC+5PMC+5

2. Achilles tendon lengthening
   If the calf muscle and Achilles tendon become too tight, the heel may not touch the ground, worsening foot deformity and causing toe-walking. A surgical lengthening procedure allows the heel to come down and improves gait. It is often combined with other foot procedures and followed by casting and intensive physiotherapy. www.elsevier.com+1

3. Toe correction surgery (for claw or hammer toes)
   Clawed toes can rub on shoes, cause corns and ulcers, and make balance worse. Surgeons may straighten the toes by releasing tight tendons, removing small pieces of bone, or fusing small joints. The goal is to reduce pain, make shoe fitting easier, and improve stability. ENMC+2Charcot-Marie-Tooth Disease+2

4. Spinal fusion for scoliosis
   Some people with CMT develop progressive scoliosis that does not respond to bracing. Spinal fusion surgery joins selected vertebrae using bone grafts and metal rods to correct curvature and prevent further worsening. The procedure can improve sitting balance, lung space, and pain, but it is major surgery that requires careful planning and rehabilitation. POSNA+4PubMed+4Charcot-Marie-Tooth Disease+4

5. Joint stabilization procedures
   If ankle or other joints become very unstable and lead to repeated sprains or falls, surgeons may perform ligament reconstruction or, in severe cases, joint fusion. Stabilizing the joint can reduce pain and improve safety while walking, although some motion is lost. Surgery decisions always weigh benefits, risks, and how fast CMT4K is progressing. JNNP+3PMC+3Charcot-Marie-Tooth Association+3

---

Preventions

1. Early diagnosis and regular follow-up at a neuromuscular or mitochondrial center.

2. Daily gentle stretching to maintain joint range and reduce contractures. PMC+1

3. Using braces, safe footwear, and walking aids before frequent falls start. Muscular Dystrophy Association+1

4. Protecting feet from injury (no barefoot walking on rough surfaces; daily foot checks). nhs.uk+1

5. Maintaining a healthy weight through diet and activity to reduce stress on weak muscles. nhs.uk

6. Avoiding smoking and heavy alcohol use, which can worsen nerve and heart health.

7. Checking and treating vitamin deficiencies, especially vitamin D and B12. Cleveland Clinic+2AAFP+2

8. Reviewing all new medicines with a neurologist to avoid drugs that can damage nerves or mitochondria when alternatives exist. nhs.uk+1

9. Early monitoring and bracing for scoliosis and foot deformity to delay or reduce the need for complex surgery. nhs.uk+1

10. Genetic counseling for family planning and early testing of at-risk siblings. NCBI+1

---

When to See Doctors

You should see a neurologist or your usual doctor regularly for planned follow-ups, but urgent review is needed if:

• Walking suddenly becomes much worse, or new frequent falls appear.

• New severe pain, burning, or electric shocks in the limbs start or sharply increase.

• You notice new curvature of the spine, rapid worsening of posture, or uneven shoulder height. PubMed+1

• Breathing becomes difficult, especially when lying flat, or there is new snoring or pauses in breathing during sleep.

• Swallowing problems, choking, or unexplained weight loss appear.

• Mood changes, depression, or anxiety become strong enough to interfere with school, work, or relationships. PMC

• There are signs of serious drug side effects, such as allergic rash, strong dizziness, suicidal thoughts, or swelling of face and tongue, after starting a new medicine. FDA Access Data+3FDA Access Data+3FDA Access Data+3

In any emergency—such as trouble breathing, chest pain, or sudden inability to move a limb—local emergency services should be contacted immediately.

---

What to Eat and What to Avoid

1. Eat: A balanced, Mediterranean-style pattern with plenty of vegetables, fruits, whole grains, legumes, nuts, and seeds to provide vitamins, minerals, and antioxidants. Frontiers+1

2. Eat: Adequate protein from fish, poultry, eggs, dairy, beans, or lentils to support muscle maintenance and healing.

3. Eat: Foods rich in healthy fats, especially omega-3 sources like oily fish (or fortified products if you follow a vegetarian diet). Frontiers

4. Eat: Foods with B-vitamins (whole grains, leafy greens, eggs, dairy) and vitamin D (fortified foods, safe sun, or prescribed supplements if levels are low). Cleveland Clinic+1

5. Eat: Enough fluid each day (water or low-sugar drinks) to prevent dehydration and support circulation.

6. Avoid: Very sugary drinks, sweets, and refined carbohydrates that promote weight gain and can worsen fatigue. nhs.uk

7. Avoid: Excessive saturated fat and deep-fried foods that can increase cardiovascular risk.

8. Avoid: Heavy alcohol use, which can directly damage nerves and interact with medicines used for neuropathic pain. nhs.uk

9. Avoid: Unsupervised mega-doses of supplements bought online, especially “miracle” nerve or stem-cell products without strong clinical evidence. PubMed+2ScienceDirect+2

10. Avoid: Extreme diets that sharply cut calories or whole food groups, because they can lead to vitamin deficiencies and muscle loss in someone who already has weak muscles. nhs.uk+1

---

Frequently Asked Questions

1. Is CMT4K curable?
   No. At present, CMT4K has no cure because it comes from a change in the SURF1 gene. Treatment focuses on symptoms, preserving movement, and improving quality of life while research explores gene and stem-cell therapies. NCBI+2Monarch Initiative+2

2. Is CMT4K always inherited from both parents?
   Yes, CMT4K is autosomal recessive, which means a child needs two non-working copies of the gene, one from each carrier parent. Carriers usually do not have symptoms. Genetic counseling can explain risks for future children. NCBI+1

3. Can exercise make CMT4K worse?
   Gentle, supervised exercise does not usually make CMT worse and can improve strength, stamina, and function. Over-intense or unsupervised exercise that causes pain or exhaustion may be harmful, so programs should be designed by therapists experienced with neuromuscular disease. SAGE Journals+3PubMed+3PMC+3

4. Will my child end up in a wheelchair?
   Some people with severe CMT4 forms may eventually need a wheelchair, at least for longer distances. However, braces, physiotherapy, and early foot surgery can delay or reduce the need for full-time wheelchair use. The pattern is very individual. Muscular Dystrophy Association+2PMC+2

5. Does CMT4K affect life expectancy?
   Many people with CMT have a near-normal life span, though severe subtypes like CMT4K can bring more disability. Good care for breathing, heart health, nutrition, and infection prevention is important to protect long-term health. NCBI+2Monarch Initiative+2

6. Are pain medicines for CMT4K the same as for other neuropathies?
   Yes. Most medicines used in CMT-related neuropathic pain—like gabapentin, pregabalin, duloxetine, and certain tricyclic antidepressants—are borrowed from evidence in diabetic and post-herpetic neuropathy. They are chosen based on symptoms and side-effect profiles, not on the exact genetic cause. Best Practice Advocacy Centre+5Charcot-Marie-Tooth Association+5Springer+5

7. Can diet cure CMT4K?
   No diet can cure the gene change, but a healthy eating pattern can help manage weight, energy, and bone health. Correcting vitamin deficiencies, especially vitamin D and B12, is important because they can cause extra nerve or muscle problems if left untreated. The Times of India+3Cleveland Clinic+3nhs.uk+3

8. Should everyone with CMT4K take CoQ10 or alpha-lipoic acid?
   Not automatically. These supplements may have a role in some mitochondrial disorders or neuropathies, but evidence is mixed and dosing can be complex. Decisions should be made with a neurologist or mitochondrial specialist after checking overall health and other medicines. SAGE Journals+4PubMed+4ScienceDirect+4

9. Is stem-cell treatment available in routine clinics for CMT4K?
   No. Stem-cell therapies for hereditary neuropathy are still experimental and should only be received within approved clinical trials. Commercial clinics that promise cures without strong evidence can be unsafe and very expensive. SAGE Journals+4CMT Research Foundation+4ScienceDirect+4

10. Will surgery stop my CMT from getting worse?
    Surgery can correct deformities and improve function but does not change the underlying nerve disease. Over time, muscles may still weaken, but a well-planned operation can give many years of better walking, less pain, and easier shoe fitting. Wiley Online Library+4PMC+4NMD Journal+4

11. Can CMT4K affect school performance?
    CMT4K mainly affects nerves in the limbs, but fatigue, pain, and hospital visits can interrupt learning. Some children may also have coordination or attention challenges. With accommodations, therapy, and emotional support, most can succeed in school.

12. Is pregnancy safe in women with CMT4K?
    Many women with CMT have safe pregnancies, but extra planning is needed. Muscle weakness, balance issues, and possible respiratory involvement must be reviewed before pregnancy. An obstetrician and neurologist can plan safe delivery and anesthesia strategies. Muscular Dystrophy Association+1

13. Can my brothers and sisters also have CMT4K?
    Siblings of a person with CMT4K have a 25% chance of also having the condition, a 50% chance of being carriers without symptoms, and a 25% chance of having two normal copies—if both parents are carriers. Genetic testing and counseling can clarify each person’s status. NCBI+1

14. Should we join a patient organization or research registry?
    Yes, if possible. Patient organizations and registries connect families with expert information, support groups, and updates about new clinical trials. They also help researchers understand the natural history of rare subtypes like CMT4K. CMT Research Foundation+2Muscular Dystrophy Association+2

15. What is the most important message for families living with CMT4K?
    CMT4K is serious and lifelong, but there are many ways to protect movement, independence, and mental health. A combination of physiotherapy, orthoses, symptom-based medicines, good nutrition, and emotional support—guided by experienced specialists—can help the person live a full and meaningful life while science works toward better targeted treatments. MDPI+3Muscular Dystrophy Association+3ScienceDirect+3

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 31, 2025.